Zealand Pharma A/S reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was DKK 10.41 million compared to DKK 25.39 million a year ago. Net loss was DKK 319.5 million compared to DKK 488.5 million a year ago. Basic loss per share from continuing operations was DKK 5.5 compared to DKK 9.77 a year ago. Basic loss per share was DKK 5.5 compared to DKK 11.04 a year ago.
For the six months, sales was DKK 24.04 million compared to DKK 36.35 million a year ago. Net loss was DKK 513.13 million compared to DKK 711.35 million a year ago. Basic loss per share from continuing operations was DKK 9.36 compared to DKK 14.03 a year ago. Basic loss per share was DKK 9.36 compared to DKK 16.27 a year ago.